BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 18194408)

  • 1. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 2. The Hanover Consensus: helpful for German decision-makers?
    Kolominsky-Rabas PL; Caro JJ
    Value Health; 2008; 11(4):545-6; discussion 547-8. PubMed ID: 18489522
    [No Abstract]   [Full Text] [Related]  

  • 3. [German recommendations for health care economic evaluation studies. Revised version of the Hannover consensus. Hannover Consensus Group].
    Med Klin (Munich); 2000 Jan; 95(1):52-5. PubMed ID: 10668346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case.
    Maetzel A; Tugwell P; Boers M; Guillemin F; Coyle D; Drummond M; Wong JB; Gabriel SE;
    J Rheumatol; 2003 Apr; 30(4):891-6. PubMed ID: 12672224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [German recommendations for health economic evaluation. Revised edition of the Hannoverian consensus. Hannoverian Consensus Group].
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1503-6. PubMed ID: 10629671
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health economic evaluation of rehabilitation programmes in the "rehabilitation sciences" research funding programme in Germany].
    Krauth C; Hessel F; Klingelhöfer HE; Schweikert B; Hansmeier T; Wasem J
    Rehabilitation (Stuttg); 2005 Oct; 44(5):297-306. PubMed ID: 16208593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic evaluation of health interventions. Spending health money: making good choices].
    Vail S
    Krankenpfl Soins Infirm; 1996 Apr; 89(4):26-8. PubMed ID: 8715976
    [No Abstract]   [Full Text] [Related]  

  • 9. The anatomy of cost estimates--the "other" outcome.
    Wolff N; Helminiak TW
    Adv Health Econ Health Serv Res; 1993; 14():159-80. PubMed ID: 10164711
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic evaluation in clinical nephrology: Part 1. An introduction to conducting an economic evaluation in clinical practice.
    Wong G; Howard K; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):434-40. PubMed ID: 20609095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.
    Bansback N; Maetzel A; Drummond M; Anis A; Marra C; Conway P; Boers M; Tugwell P; Boonen A
    J Rheumatol; 2007 May; 34(5):1178-83. PubMed ID: 17477483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustainable health care for Canada.
    Maxwell J; Angus D; Albert T
    Leadersh Health Serv; 1995; 4(1):27-31. PubMed ID: 10140965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for economic evaluations of non-pharmacological arthritis care: results from the CARE VI meeting 2010.
    van den Hout WB; Bremander A; Vliet Vlieland TP
    Musculoskeletal Care; 2011 Jun; 9(2):120-3. PubMed ID: 21365738
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
    Al MJ; Feenstra TL; Hout BA
    Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using databases for studying and comparing health care costs and resource use.
    Melfi CA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):399-402. PubMed ID: 11802584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficult decisions: weighing treatment costs and benefits.
    Wainio JA
    Hosp Technol Ser; 1995 Jan; 14(1):1-3. PubMed ID: 10140805
    [No Abstract]   [Full Text] [Related]  

  • 18. Equity and the economic evaluation of healthcare.
    Sassi F; Archard L; Le Grand J
    Health Technol Assess; 2001; 5(3):1-138. PubMed ID: 11207451
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in economic outcomes research.
    Cook JR
    Hepatology; 1999 Jun; 29(6 Suppl):23S-25S. PubMed ID: 10386079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods.
    Stollenwerk B; Stock S; Siebert U; Lauterbach KW; Holle R
    Med Decis Making; 2010; 30(3):304-13. PubMed ID: 19815659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.